Lead Cell Therapy Program

About Rinri Therapeutics

Rinri Therapeutics is a private, clinical-stage biotech focused on a groundbreaking therapeutic area: regenerative cell therapy for hearing loss. The company leverages foundational research in auditory stem cells from Professor Marcelo Rivolta at the University of Sheffield. With a portfolio of first-in-class programs, Rinri aims to address the significant unmet medical need in sensorineural hearing loss, a condition with no current curative treatments. The company is positioned as a leader in translating auditory regeneration science into clinical reality.

Therapeutic Areas

Other Sensorineural Hearing Loss Drugs